Brand Meditech (AED)

Market Price (10/26/2026): $0 | Market Cap: $-Sector: Health Care | Industry: Life Sciences Tools & Services

Brand Meditech (AED)

Market Price (10/26/2026): $0
Market Cap: $-
Sector: Health Care
Industry: Life Sciences Tools & Services

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

null

AED in ETFs

Weight = AED's share of each fund

SCHC0.25%

FNDC0.08%

Valuation & Metrics

	10/26/26	2025	2024
Share Price	$0.00	�	�
Mkt Cap ($ Mil)	-	-	-
+ Debt ($ Mil)	0.0	0.0	0.0
- Cash ($ Mil)	0.0	0.0	0.0
TEV ($ Mil)	-
Valuation Ratios
P/S	-	-	-
P/EBIT	-	-	-
P/E	-	-	-
P/FCF	-	-	-
Sector Ratios (* = sector average)
P/S *	3.7	4.0	3.9
P/EBIT *	-1.5	-1.5	-1.4
P/E *	-1.4	-1.7	-1.7
P/FCF *	-1.5	-1.7	-1.5

	10/26/26	2025	2024
Share Price	$0.00	�	�
Mkt Cap ($ Mil)	-	-	-
+ Debt ($ Mil)	0.0	0.0	0.0
- Cash ($ Mil)	0.0	0.0	0.0
TEV ($ Mil)	-
Valuation Ratios
P/S	-	-	-
P/EBIT	-	-	-
P/E	-	-	-
P/FCF	-	-	-
Sector Ratios (* = sector average)
P/S *	3.7	4.0	3.9
P/EBIT *	-1.5	-1.5	-1.4
P/E *	-1.4	-1.7	-1.7
P/FCF *	-1.5	-1.7	-1.5

null

AI Analysis | Feedback

Metric

Price Chart

null

No Events

Why The Stock Moved

Stock Movement Drivers

Fundamental Drivers

null
null

Market Drivers

6/30/2026 to 10/24/2026

	Return	Correlation
AED	0.0%
Market (SPY)	1.8%	�
Sector (XLV)	13.0%	�

Fundamental Drivers

null
null

Market Drivers

3/31/2026 to 10/24/2026

	Return	Correlation
AED	0.0%
Market (SPY)	17.2%	�
Sector (XLV)	22.8%	�

Fundamental Drivers

null
null

Market Drivers

9/30/2025 to 10/24/2026

	Return	Correlation
AED	0.0%
Market (SPY)	15.0%	�
Sector (XLV)	30.5%	�

Fundamental Drivers

null
null

Market Drivers

9/30/2023 to 10/24/2026

	Return	Correlation
AED	0.0%
Market (SPY)	83.9%	�
Sector (XLV)	45.8%	�

Return vs. Risk

Price Returns Compared

	2021	2022	2023	2024	2025	2026	Total [1]
Returns
AED Return	-	-	-	-	-	-	-
Peers Return	12%	-10%	18%	16%	9%	-18%	24%
S&P 500 Return	27%	-19%	24%	23%	16%	12%	104%
Monthly Win Rates [3]
AED Win Rate	-	-	-	-	-	-
Peers Win Rate	52%	48%	53%	58%	57%	48%
S&P 500 Win Rate	75%	42%	67%	75%	67%	50%
Max Drawdowns [4]
AED Max Drawdown	-	-	-	-	-	-
Peers Max Drawdown	-19%	-30%	-18%	-14%	-19%	-37%
S&P 500 Max Drawdown	-5%	-25%	-10%	-8%	-19%	-9%

[1] Cumulative total returns since the beginning of 2021
[2] Peers: MDT, SYK, BSX, ABT, GEHC.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 10/23/2026 (YTD)

Event	AED	S&P 500
2013 Taper Tantrum
% Loss	-10.0%	-0.2%
% Gain to Breakeven	11.1%	0.2%
Time to Breakeven	214 days	1 days
2011 US Debt Ceiling Crisis & European Contagion
% Loss	-25.4%	-17.9%
% Gain to Breakeven	34.1%	21.8%
Time to Breakeven	198 days	123 days
2010 Eurozone Sovereign Debt Crisis / Flash Crash
% Loss	-18.5%	-15.4%
% Gain to Breakeven	22.7%	18.2%
Time to Breakeven	68 days	125 days
2008-2009 Global Financial Crisis
% Loss	-61.8%	-53.4%
% Gain to Breakeven	162.0%	114.4%
Time to Breakeven	28 days	1085 days

Compare to MDT, SYK, BSX, ABT, GEHC

In The Past

Brand Meditech's stock fell -2.8% during the Q4 2018 Fed Policy Error / Growth Scare. Such a loss loss requires a 2.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

Event	AED	S&P 500
2011 US Debt Ceiling Crisis & European Contagion
% Loss	-25.4%	-17.9%
% Gain to Breakeven	34.1%	21.8%
Time to Breakeven	198 days	123 days
2008-2009 Global Financial Crisis
% Loss	-61.8%	-53.4%
% Gain to Breakeven	162.0%	114.4%
Time to Breakeven	28 days	1085 days

Compare to MDT, SYK, BSX, ABT, GEHC

In The Past

Brand Meditech's stock fell -2.8% during the Q4 2018 Fed Policy Error / Growth Scare. Such a loss loss requires a 2.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Brand Meditech (AED)

Business Description

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

AI Analysis | Feedback

null

Interactive Breakdown

null

null

Better Bets vs. Brand Meditech (AED)

null

Peer Outperformance in null

null null

null

Latest Trefis Analyses

null

Trade Ideas

Select ideas related to AED.

null

Recent Active Movers

Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
RHI	Robert Half	4.6	21.7%	79.4%
NN	NextNav	1.4	9.4%	-39.4%
ENVX	Enovix	0.6	9.4%	-61.8%
AVBP	ArriVent BioPharma	1.0	9.4%	4.4%
NTSK	Netskope	9.7	9.4%	38.4%
THRM	Gentherm	0.9	9.4%	-16.7%
VG	Venture Global	34.8	9.3%	106.4%
CART	Maplebear	13.3	9.2%	25.5%
BAND	Bandwidth	1.4	9.1%	186.0%
CCI	Crown Castle	37.2	9.1%	0.5%

Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
LKQ	LKQ	4.4	-22.5%	-40.4%
CORT	Corcept Therapeutics	9.0	-20.1%	146.7%
PHAT	Phathom Pharmaceuticals	0.5	-18.1%	-65.4%
TNGX	Tango Therapeutics	3.5	-16.4%	163.4%
WGS	GeneDx	1.7	-16.4%	-56.8%
BE	Bloom Energy	55.5	-11.2%	122.5%
SLM	SLM	3.7	-10.8%	-27.0%
STC	Stewart Information Services	1.3	-10.5%	-35.7%
BLMN	Bloomin Brands	0.8	-10.4%	49.1%
GPGI	GPGI	3.3	-9.6%	-41.2%

Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
BRZE	Braze	5.1	56.4%	33.8%
RHI	Robert Half	4.6	37.7%	79.4%
IRON	Disc Medicine	2.9	31.1%	-6.2%
TRON	Tron	0.7	29.9%	15.7%
TRAX	First Tracks Biotherapeutics	1.5	27.8%	136.8%
NTSK	Netskope	9.7	27.8%	38.4%
MANE	Veradermics	5.6	27.5%	267.6%
APPN	Appian	3.8	27.2%	47.8%
AVBP	ArriVent BioPharma	1.0	26.1%	4.4%
DGICB	Donegal	-	25.7%	39.3%

Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
AVTX	Avalo Therapeutics	0.3	-38.5%	-61.8%
GLAS	Glass House Brands	0.2	-32.9%	-75.8%
AVEX	AEVEX	0.6	-29.5%	-59.8%
NVEC	NVE	0.4	-26.7%	26.8%
KALU	Kaiser Aluminum	1.8	-26.7%	-4.6%
CRS	Carpenter Technology	14.1	-24.5%	-9.4%
FPS	Forgent Power Solutions	5.9	-23.5%	-16.5%
CORT	Corcept Therapeutics	9.0	-22.1%	146.7%
LKQ	LKQ	4.4	-21.6%	-40.4%
FCFS	FirstCash	7.6	-19.7%	9.1%

Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
KOD	Kodiak Sciences	5.5	163.8%	213.4%
BRZE	Braze	5.1	86.0%	33.8%
FIGS	FIGS	3.4	61.7%	77.8%
HPK	HighPeak Energy	1.4	51.2%	144.1%
DXC	DXC Technology	2.6	48.8%	9.8%
TTAN	ServiceTitan	8.3	45.1%	-18.3%
RXO	RXO	4.9	44.3%	127.5%
KSS	Kohl's	2.8	42.6%	23.4%
PCRX	Pacira BioSciences	1.4	42.5%	40.7%
ACN	Accenture	152.7	41.7%	-3.8%

Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
GLAS	Glass House Brands	0.2	-70.1%	-75.8%
SHAZ	SharonAI	0.4	-59.3%	-75.2%
NUAI	New Era Energy & Digital	0.3	-57.3%	1.0%
BRUN	Boost Run	0.4	-56.8%	-65.5%
CIFR	Cipher Digital	3.3	-56.1%	-46.2%
AVTX	Avalo Therapeutics	0.3	-55.9%	-61.8%
EMAT	Evolution Metals & Technologies	0.9	-55.5%	-93.3%
FRVO	Fervo Energy	1.3	-51.9%	-78.0%
XNDU	Xanadu Quantum Technologies	0.8	-48.2%	-77.0%
FMC	FMC	0.6	-46.9%	-62.8%

Peer Comparisons

Peers to compare with:

Financials

	AED	MDT	SYK	BSX	ABT	GEHC	Median
Name	Brand Me.	Medtronic	Stryker	Boston S.	Abbott L.	GE Healt.
Mkt Price	-	95.72	306.50	45.57	103.80	71.44	95.72
Mkt Cap	-	122.5	117.5	67.0	180.7	32.4	117.5
Rev LTM	-	37,541	25,837	20,996	46,585	21,267	25,837
Op Inc LTM	-	7,147	5,615	4,409	7,346	2,733	5,615
FCF LTM	-	6,132	4,702	1,806	7,824	1,579	4,702
FCF 3Y Avg	-	5,527	3,843	2,224	6,751	1,587	3,843
CFO LTM	-	8,035	5,525	4,529	9,905	2,101	5,525
CFO 3Y Avg	-	7,360	4,569	3,815	8,947	2,032	4,569

Growth & Margins

	AED	MDT	SYK	BSX	ABT	GEHC	Median
Name	Brand Me.	Medtronic	Stryker	Boston S.	Abbott L.	GE Healt.
Rev Chg LTM	-	9.8%	8.5%	13.5%	8.1%	6.5%	8.5%
Rev Chg 3Y Avg	-	6.0%	9.9%	16.2%	5.1%	3.8%	6.0%
Rev Chg Q	-	13.7%	9.4%	7.5%	13.0%	5.8%	9.4%
QoQ Delta Rev Chg LTM	-	3.2%	2.2%	1.8%	3.2%	1.4%	2.2%
Op Inc Chg LTM	-	7.5%	20.4%	30.1%	-2.2%	-0.8%	7.5%
Op Inc Chg 3Y Avg	-	6.3%	16.4%	25.7%	6.5%	3.1%	6.5%
Op Mgn LTM	-	19.0%	21.7%	21.0%	15.8%	12.9%	19.0%
Op Mgn 3Y Avg	-	18.5%	20.4%	19.1%	16.4%	13.1%	18.5%
QoQ Delta Op Mgn LTM	-	0.3%	1.5%	1.1%	-1.3%	0.2%	0.3%
CFO/Rev LTM	-	21.4%	21.4%	21.6%	21.3%	9.9%	21.4%
CFO/Rev 3Y Avg	-	21.2%	19.1%	20.7%	20.5%	10.0%	20.5%
FCF/Rev LTM	-	16.3%	18.2%	8.6%	16.8%	7.4%	16.3%
FCF/Rev 3Y Avg	-	15.9%	16.1%	12.3%	15.5%	7.8%	15.5%

Valuation

	AED	MDT	SYK	BSX	ABT	GEHC	Median
Name	Brand Me.	Medtronic	Stryker	Boston S.	Abbott L.	GE Healt.
Mkt Cap	-	122.5	117.5	67.0	180.7	32.4	117.5
P/S	-	3.3	4.5	3.2	3.9	1.5	3.3
P/Op Inc	-	17.1	20.9	15.2	24.6	11.8	17.1
P/EBIT	-	16.7	20.3	15.9	21.8	10.5	16.7
P/E	-	23.4	31.5	18.2	33.3	16.3	23.4
P/CFO	-	15.2	21.3	14.8	18.2	15.4	15.4
Total Yield	-	7.3%	4.3%	5.5%	5.4%	6.3%	5.5%
Dividend Yield	-	3.0%	1.1%	0.0%	2.4%	0.2%	1.1%
FCF Yield 3Y Avg	-	5.3%	2.9%	2.1%	3.4%	4.6%	3.4%
D/E	-	0.2	0.1	0.2	0.2	0.3	0.2
Net D/E	-	0.2	0.1	0.2	0.1	0.3	0.2

Returns

	AED	MDT	SYK	BSX	ABT	GEHC	Median
Name	Brand Me.	Medtronic	Stryker	Boston S.	Abbott L.	GE Healt.
1M Rtn	-	9.0%	14.0%	2.0%	3.3%	7.7%	7.7%
3M Rtn	-	16.0%	-6.9%	3.0%	1.3%	18.0%	3.0%
6M Rtn	-	16.9%	-5.9%	-26.6%	15.4%	3.9%	3.9%
12M Rtn	-	5.6%	-18.8%	-54.9%	-16.1%	-8.4%	-16.1%
3Y Rtn	-	47.9%	21.9%	-8.8%	18.2%	11.3%	18.2%
1M Excs Rtn	-	10.1%	15.0%	3.0%	4.4%	8.7%	8.7%
3M Excs Rtn	-	11.7%	-11.5%	-2.7%	-2.9%	14.1%	-2.7%
6M Excs Rtn	-	10.4%	-12.3%	-33.0%	9.0%	-2.5%	-2.5%
12M Excs Rtn	-	-10.7%	-34.0%	-69.9%	-30.7%	-19.7%	-30.7%
3Y Excs Rtn	-	-31.7%	-59.7%	-86.6%	-61.1%	-66.5%	-61.1%

FDIC Bank Data

Bank Capital

null

Bank Deposits

null

Bank Assets

null

Bank Loans

null

FDA Approved Drugs Data

Expand for Morenull

Clinical Pipeline

null

Financials

Annual
Quarterly

$ Mil \| FY: 3/31	LTM	2025	2024
Period End	0/0/-1	3/31/2025	3/31/2024
Filing Date	0/0/-1	12/11/2025	12/11/2025
Key Financials
Total Revenue	-	25	26
Gross Profit	-	4	4
EBITDA	-	3	3
Operating Income	-	2	3
Net Income	-	1	1
EPS	-	0.11	0.14
Growth Rates
Total Revenue Growth	-	-2.7%	-
EBITDA Growth	-	-13.6%	-
Operating Income Growth	-	-15.8%	-
Net Income Growth	-	-18.0%	-
Margins
Gross Margin	-	15.7%	16.1%
EBITDA Margin	-	10.5%	11.8%
Operating Income Margin	-	9.3%	10.8%
Net Income Margin	-	4.7%	5.6%
Cash & Debt
Total Cash	�	0	0
Total Debt	0	16	14
Net Debt / (Cash)	�	16	14
Cash Flows & CapEx
Net Cash from Operations	-	-2	2
Total CapEx	0	-0	-0
Free Cash from Operations	-	-2	2
Returns to Shareholders
Dividends	0	-0	-0
Share Repurchases	-0	-0	-0

$ Mil \| FY: 3/31
Period End
Filing Date
Key Financials Quarterly
Total Revenue
Ebitda
Operating Income
Net Income
EPS
Key Financials TTM
Total Revenue TTM
Ebitda TTM
Operating Income TTM
Net Income TTM
Growth Rates Quarterly
Total Revenue Growth
EBITDA Growth
Operating Income Growth
Net Income Growth
Margins Quarterly
EBITDA Margin
Operating Income Margin
Net Income Margin
Cash & Debt
Total Cash
Total Debt
Net Debt / (Cash)
Cash Flows Quarterly
FCF from Operations
Cash Flows TTM
FCF from Operations TTM
Returns to Shareholders Quarterly
Dividends
Share Repurchases
Return on Invested Capital (ROIC) Quarterly
ROIC
Return on Invested Capital (ROIC) TTM
ROIC TTM

Segment Financials

Revenue by Segment

$ Mil	2025	2024
Sales of medical devices-third parties	21	20
Sales of medical software-third parties	4	6
Sales of medical devices-related parties	0	0
Service related to medical software-third parties	0	0
Total	25	26

Price Behavior

null

AED Betas & Captures as of 9/30/2026

	1M	2M	3M	6M	1Y	3Y
Beta	�	�	�	�	�	�
Up Beta	�	�	�	�	�	�
Down Beta	�	�	�	�	�	�
Up Capture	0%	0%	0%	0%	0%	0%
Bmk +ve Days	6	16	27	66	132	424
Stock +ve Days	0	0	0	0	0	0
Down Capture	-0%	-0%	-0%	-0%	-0%	-0%
Bmk -ve Days	16	26	37	60	120	328
Stock -ve Days	0	0	0	0	0	0

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Based On 1-Year Data

	Annualized Return	Annualized Volatility	Sharpe Ratio	Correlation with AED
AED	-	-	-	-
Sector ETF (XLV)	24.5%	16.3%	1.15	-
Equity (SPY)	14.8%	12.7%	0.80	-
Gold (GLD)	-2.8%	28.5%	-0.11	-
Commodities (DBC)	52.1%	20.7%	1.91	-
Real Estate (VNQ)	4.3%	13.9%	0.06	-
Bitcoin (BTCUSD)	-24.8%	43.5%	-0.54	-

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 5-Year Data

	Annualized Return	Annualized Volatility	Sharpe Ratio	Correlation with AED
AED	-	-	-	-
Sector ETF (XLV)	8.7%	15.3%	0.37	-
Equity (SPY)	12.7%	17.1%	0.56	-
Gold (GLD)	17.3%	18.9%	0.73	-
Commodities (DBC)	9.5%	19.5%	0.37	-
Real Estate (VNQ)	1.1%	18.9%	-0.05	-
Bitcoin (BTCUSD)	5.7%	51.7%	0.29	-

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 10-Year Data

	Annualized Return	Annualized Volatility	Sharpe Ratio	Correlation with AED
AED	-0.0%	5.9%	-0.44	-
Sector ETF (XLV)	11.7%	16.8%	0.57	7.0%
Equity (SPY)	15.3%	17.9%	0.72	11.0%
Gold (GLD)	11.8%	16.4%	0.59	4.1%
Commodities (DBC)	8.4%	18.1%	0.38	3.9%
Real Estate (VNQ)	5.2%	20.7%	0.21	3.5%
Bitcoin (BTCUSD)	62.4%	66.2%	1.02	1.9%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Returns Analyses

null

SEC Filings

Expand for More

Report Date	Filing Date	Filing
03/31/2025	12/11/2025	F-1

Recent Forward Guidance

Updated 10/24/2026

Latest: null Earnings Reported N/A/N/A/N/A

null

Insider Activity

Updated null

Expand for Morenull

Investor Activity (13F)

Updated

13F holdings as of

Pillar	Score
① Structure	0
② Vol / Mom	0
③ Catalyst	0

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

Life Sciences Tools & Services Resources

GenomeWeb

BioSpace

The Scientist

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Core Cache Last Updated: 10/24/2026

Brand Meditech (AED)

Market Price (10/26/2026): $0 | Market Cap: $-Sector: Health Care | Industry: Life Sciences Tools & Services

Brand Meditech (AED)

Market Price (10/26/2026): $0Market Cap: $-Sector: Health CareIndustry: Life Sciences Tools & Services

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

AED in ETFs

Valuation & Metrics

Price Chart

Why The Stock Moved

Qualitative Assessment

Stock Movement Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

In The Past

Preserve Wealth

Asset Allocation

About Brand Meditech (AED)

Interactive Breakdown

Better Bets vs. Brand Meditech (AED)

Peer Outperformance in null

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

Top Gainers

Top Losers

Top Gainers

Top Losers

Top Gainers

Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

FDA Approved Drugs Data

Clinical Pipeline

Financials

Segment Financials

Price Behavior

Based On 1-Year Data

Based On 5-Year Data

Based On 10-Year Data

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Recent Forward Guidance

Insider Activity

Investor Activity (13F)

AED Trade Sentinel

null

CONVICTION RATIONALE

STOCK ARCHETYPE

INVESTMENT THESIS

PRIMARY RISK

BULL VIEW

CORE TENSION

PREVAILING SENTIMENT

Market Price (10/26/2026): $0
Market Cap: $-
Sector: Health Care
Industry: Life Sciences Tools & Services